M. Hugues Lecat has been appointed Chairman and Chief Executive Officer of the Management Board of the pharmaceutical company Ethypharm.
News and Press Release
February 2010 – Hugues Lecat appointed Chairman and CEO of Ethypharm
January 2010 – Axorid ® : further collaboration with Meda
Ethypharm and Meda have just spread their collaboration for the marketing of Axorid ® in Eastern Europe. This “once a day” formulation is the first fixed association of ketoprofen with omeprazole, developed by Ethypharm. The first agreement, signed in 2007, concerned Western and Central Europe.
October 2009 – Launching of Oxycodone Flashtab®
October 2009, Paris – France : Ethypharm announce the launch, by Mundipharma, in France and in Germany of an Orodispersible form of Oxycodone marketed under the name of OxynormOro® and Oxynorm Dispersa®.
September 2009 – FDA concludes inspections at two facilities
Ethypharm, a pharmaceutical technology based company, announced that United States Food and Drug Administration (FDA) recently completed two Inspections at its manufacturing facilities.
April 2009 – Ethypharm and Archimedes expand collaboration
ETHYPHARM announced it has signed two agreements with the pan-European company Archimedes Pharma Limited.
